Principal Investigator
David Baidal
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230453
Clinical Trial Summary
JAK Inhibitor
Phase
TBD
Funding Agency/Sponsor
Other
Disease
Other